SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HEPATITIS C VIRUS / HIV-ASSOCIATED MALIGNANCIES
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
8 of
8
|
RETREATMENT OF HEPATITIS C INFECTION IN PATIENTS WHO FAILED GLECAPREVIR/PIBRENTASVIR (ABSTRACT
127)
David L. Wyles
Denver Health and Hospital Authority, Denver, CO, USA
8 WEEKS OF GRAZOPREVIR/ELBASVIR FOR ACUTE HCV: A MULTICENTER CLINICAL TRIAL (DAHHS 2) (ABSTRACT
128)
Anne Boerekamps
Erasmus Medical Center, Rotterdam, Netherlands
FUELING THE EPIDEMIC: LOW RATES OF SPONTANEOUS CLEARANCE OF ACUTE HCV COINFECTION (ABSTRACT
129)
Christoph Boesecke
University Hospital Bonn, Bonn, Germany
INTERNATIONAL VERSUS DOMESTIC HCV TRANSMISSION IN MSM: A PERSPECTIVE FOR THE DAA ERA (ABSTRACT
130)
Luisa Salazar-Vizcaya
University Hospital Bern, Inselspital, Bern, Switzerland
ITAP TRIAL: MATERNAL AND INFANT EFFICACY AND SAFETY RESULTS 12 MONTHS AFTER DELIVERY (ABSTRACT
131)
Gonzague Jourdain
Institut de recherche pour le développement, Chiang Mai, Chiang Mai, Thailand
STATIN EXPOSURE IS ASSOCIATED WITH DECREASED RISK OF CANCER (ABSTRACT
132)
Roger Bedimo
VA North Texas Health Care Center, Dallas, TX, USA
PREDICTORS OF KS-IRIS IN MILD/MODERATE AIDS-KS DURING ART IN LOW-RESOURCE SETTINGS (ABSTRACT
133)
Thomas Campbell
University of Colorado Denver, Aurora, CO, USA
ACTG 5282: HPV TEST&TREAT VS CYTOLOGY-BASED CERVICAL CANCER PREVENTION IN HIV+ WOMEN (ABSTRACT
134)
Timothy Wilkin
Weill Cornell Medicine, New York, NY, USA
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
8 of
8
|